Sudden Cardiac Death: Opportunities for Prevention

Overview

Journal Heart

Date 2005 Sep 15

PMID 16159972

Citations 2

Authors

J M Morgan

J C Cowan

A J Camm

J M McComb

Affiliations

Soon will be listed here.

Abstract

The evidence base for implantable cardioverter-defibrillator (ICD) therapy requires expansion of guidance/indications to allow UK physicians to treat a broader range of patients. The ICD clinical consultees to the National Institute for Health and Clinical Excellence (NICE) review current guidance/guidelines, explain the evidence base, and suggest a UK ICD implantation strategy.

Citing Articles

Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy.

Arisoy F, Celebi O, Erbay I, Tufekcioglu O, Aydogdu S, Temizhan A J Arrhythm. 2021; 37(4):1046-1051.

PMID: 34386131 PMC: 8339102. DOI: 10.1002/joa3.12571.

Effective communication and ethical consent in decisions related to ICDs.

Clark A, Jaarsma T, Strachan P, Davidson P, Jerke M, Beattie J Nat Rev Cardiol. 2011; 8(12):694-705.

PMID: 21788961 DOI: 10.1038/nrcardio.2011.101.

References

Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G . A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999; 341(25):1882-90. DOI: 10.1056/NEJM199912163412503. View

Tang A, Ross H, Simpson C, Mitchell L, Dorian P, Goeree R . Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol. 2005; 21 Suppl A:11A-18A. View

Sheldon R, OBrien B, Blackhouse G, Goeree R, Mitchell B, Klein G . Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study. Circulation. 2001; 104(14):1622-6. DOI: 10.1161/hc3901.096720. View

Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877-83. DOI: 10.1056/NEJMoa013474. View

Brodsky M, Mitchell L, Halperin B, Raitt M, Hallstrom A . Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am Heart J. 2002; 144(3):478-84. DOI: 10.1067/mhj.2002.125502. View

Abrams J, Epstein A, Freedman R, Hayes D, Hlatky M, Kerber R . ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE.... Circulation. 2002; 106(16):2145-61. DOI: 10.1161/01.cir.0000035996.46455.09. View

Wilkoff B, Cook J, Epstein A, Greene H, Hallstrom A, Hsia H . Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2003; 288(24):3115-23. DOI: 10.1001/jama.288.24.3115. View

Priori S, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P . Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003; 24(1):13-5. DOI: 10.1016/s0195-0668x(02)00809-6. View

Burke J, Hallas C, Clark-Carter D, White D, Connelly D . The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br J Health Psychol. 2003; 8(Pt 2):165-78. DOI: 10.1348/135910703321649141. View

10.

Cappato R, Boczor S, Kuck K . Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy. Eur Heart J. 2004; 25(8):642-9. DOI: 10.1016/j.ehj.2004.01.009. View

11.

Salukhe T, Dimopoulos K, Sutton R, Coats A, Piepoli M, Francis D . Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications. Circulation. 2004; 109(15):1848-53. DOI: 10.1161/01.CIR.0000125522.10053.29. View

12.

Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P . Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2004; 110(2):112-6. DOI: 10.1161/01.CIR.0000134957.51747.6E. View

13.

MOSS A, Hall W, Cannom D, Daubert J, Higgins S, Klein H . Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996; 335(26):1933-40. DOI: 10.1056/NEJM199612263352601. View

14.

Domanski M, Sakseena S, EPSTEIN A, Hallstrom A, Brodsky M, Kim S . Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics.... J Am Coll Cardiol. 1999; 34(4):1090-5. DOI: 10.1016/s0735-1097(99)00327-7. View

15.

Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View

16.

Al-Khatib S, Anstrom K, Eisenstein E, Peterson E, Jollis J, Mark D . Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med. 2005; 142(8):593-600. DOI: 10.7326/0003-4819-142-8-200504190-00007. View

17.

Buxton A . Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation. 2005; 111(19):2537-49. DOI: 10.1161/01.CIR.0000165057.88551.2C. View

18.

Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M . Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005; 26(11):1115-40. DOI: 10.1093/eurheartj/ehi204. View

19.

Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M . Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation. 2000; 101(14):1660-4. DOI: 10.1161/01.cir.101.14.1660. View